Elaine Kulm

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome”.

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

Blood(2022)10.1182/blood.2022018546

N/A

3.2DataRank · unranked

132 citations

Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +17 more

Interim analysis: Open-label extension study of leniolisib for patients with APDS

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.09.032

N/A

1.2DataRank · unranked

40 citations

Elaine Kulm, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +15 more

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome

Blood Advances(2024)10.1182/bloodadvances.2023011000

N/A

0.637DataRank · unranked

15 citations

Elaine Kulm, Jennifer Grossman, David Buchbinder, Hey Chong, Jason Bradt +5 more

The contribution of rare copy number variants in FAS toward pathogenesis of autoimmune lymphoproliferative syndrome

Blood Advances(2022)10.1182/bloodadvances.2021005835

N/A

0DataRank · unranked

10 citations

Susan Price, Morgan N Similuk, Elaine Kulm, Jia Yan, Michael Setzer +6 more

Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function

Blood(2020)10.1182/blood.2020009620

N/A

0DataRank · unranked

103 citations

Alicia Bach, Saara Kaviany, Luana Chiquetto Paracatu, Maleewan Kitcharoensakkul, Magdalena Walkiewicz +31 more

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis

Clinical Immunology(2024)10.1016/j.clim.2024.110400

N/A

0DataRank · unranked

16 citations

Anna Šedivá, Virgil A. S. H. Dalm, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +14 more

Leniolisib treatment for people with activated PI3K delta syndrome (APDS): a plain language summary of the phase 3 study

Future Rare Diseases(2024)10.1080/23995270.2024.2379239

N/A

0DataRank · unranked

0 citations

Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Niall Conlon +6 more